基于预培训的相关性意识访问类似性网络对药物推的建议
IEEE journal of biomedical and health informatics
|July 18, 2025
概括
这项研究介绍了RaVSNet,这是电子健康记录 (EHR) 药物推的新方法. 它通过考虑访问相似性和医疗相关性来增强患者建模,从而导致更准确的药物建议.
科学领域:
- 生物医学信息学 生物医学信息学
- 医疗保健中的人工智能
- 临床决策支持 临床决策支持
背景情况:
- 电子健康记录 (EHR) 能够推药物,但由于数据稀疏和患者的模两可相似性,它面临着挑战.
- 精确的患者建模至关重要,需要分析疾病进展和类似患者的药物历史.
研究的目的:
- 开发一种先进的药物推系统,克服电子健康记录数据的局限性.
- 通过整合参观相似性和医学知识来提高药物建议的准确性和相关性.
主要方法:
- 拟议的RaVSNet (相关性意识访问相似性网络) 利用纵向和横向访问相似性.
- 综合医疗相关性知识,并使用相关性意识网络进行条件-药物匹配.
- 引入了一个预训练框架,其中包括药物序列重建 (MSR) 和因果效应推理 (CEI) 任务.
主要成果:
- 在MIMIC-III和MIMIC-IV数据集上,RaVSNet在最先进的方法上表现出优越的性能.
- 实现了更准确的药物推组合.
- 在与其他药物推方法相结合时,预培训框架提高了绩效.
结论:
- 通过增强的患者建模,RaVSNet有效地解决了基于EHR的药物推方面的挑战.
- 拟议的预培训框架提供了一种可通用的方法,以提高药物推的性能.
- 这项工作推动了人工智能在个性化医学和临床决策支持方面的应用.
更多相关视频
相关概念视频
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Drug Regulation
1.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.9K


